Related Experiment Video

Updated: Jul 8, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

9.9K

Evidence-based incorporation of key parameters into MELD score for acute-on-chronic liver failure

Xia Yu1, Ruoqi Zhou1, Wenting Tan2

  • 1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Egastroenterology
|February 13, 2025
PubMed
Abstract

Insights

A new CATCH-LIFE-MELD score improves prediction of short-term outcomes for acute-on-chronic liver failure (ACLF). This modified score, incorporating age, neutrophil count, and hepatic encephalopathy grade, offers superior accuracy over traditional models for ACLF prognostication.

Area of Science:

  • Hepatology
  • Prognostic modeling
  • Clinical prediction rules

Background:

  • The Model for End-Stage Liver Disease (MELD) score is a standard prognostic tool for end-stage liver disease but shows limited accuracy in predicting outcomes for acute-on-chronic liver failure (ACLF).
  • There is a critical need for improved prognostic models to guide clinical management and resource allocation in ACLF patients.

Purpose of the Study:

  • To identify novel predictive parameters for ACLF outcomes.
  • To develop and validate a reformed MELD score for more accurate ACLF prognostication.

Main Methods:

  • A meta-analysis of 32 cohort studies (13,939 patients) identified potential predictive factors for 28-day/90-day ACLF outcomes.
  • Three factors (age, neutrophil count, hepatic encephalopathy grade) were validated alongside the MELD score in two prospective cohorts (751 ACLF patients).
  • A new score, the Chinese Acute-on-Chronic Liver Failure Consortium (CATCH-LIFE)-MELD score, was developed and evaluated for discrimination and calibration.

Main Results:

  • The CATCH-LIFE-MELD score (0.028×age + 0.3×HE grade + 0.039×neutrophil count + 0.079×MELD score) demonstrated superior predictive performance (concordance index 0.791/0.788 for 28-day/90-day outcomes) compared to traditional scores.
  • Statistical analyses including net reclassification improvement and integrated discrimination improvement confirmed the model's enhanced accuracy.
  • The CATCH-LIFE-MELD score's accuracy remained robust across various patient subgroups and was validated in an external cohort.

Conclusions:

  • The CATCH-LIFE-MELD score represents a significant advancement in predicting the short-term prognosis of ACLF.
  • This modified MELD score offers improved accuracy and clinical utility compared to existing prognostic tools for ACLF.

More Related Videos

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

4.3K
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics11:02

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

425

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...